| Term 
 | Definition 
 
        | CNS=brain & spinal cord PNS= autonomic-smooth muscle,  sympathetic (thoracic and lumbar) short pre and long post=fight or flight,  parasympathetic (cranial and cervical) long pre and short post-rest and digest,  somatic-skeletal muscle |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sypathetic: Acetylcholine, Norepi, Nicotinic= adrenergic muscarinic (swat glands) Parasympathetic: Acetylchoine, Nicotinic=muscarinic Somatic: Acetylcholine = nicotinic  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nicotinic- Stimulated by ACh, Norepi   Catecholamines- Dopamine, Norepi, epi, MAOI's-Tyramine       Tyrosine converted into L-dopa converted into dopamine packaged into vesicles and turns itno epi then turned into norepi Tyramin acts as a Dopamine, Norepi, Epi releasing agent.  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Used to decrease BP, Cardiac Arrest, Premature Labor.   Break down Catecholamines |  | 
        |  | 
        
        | Term 
 
        | Sympathomemetic Drugs   Direct Acting |  | Definition 
 
        | A2 Agonist (- feedback): Clonidine B2 Agonist: Albuterol, Terbutaline. |  | 
        |  | 
        
        | Term 
 
        | Sympathomemetic Drugs   Indirect Acting |  | Definition 
 
        | Methampethamine: Increase release of NE anddopamine, and increase CNS effects   Amphetamine: increase release of NE and dopamine with more CNS effects   Ritalin: used for ADHD |  | 
        |  | 
        
        | Term 
 
        | Adrenoreceptor Antagonists   Alpha-antagonists: Phentolamine, Doxazosin, Prazosin, Yohimbine |  | Definition 
 
        | Block catecholamines from binding to a1 and a2 receptors   Decrease BP, Vasodilation   SE: Cardiac postural hypotension, decreased PVR, muscle relaxation, ease micturition, pupil constrict, increase nasal stuffiness. |  | 
        |  | 
        
        | Term 
 
        | Adrenoreceptor Antagonists   B-antagonists: Metoprolol, Atenolol, timolol |  | Definition 
 
        | Will always be stronger than b agonists   SE: decrease BP, CO, increase NA retention, increase airway resistance, decrease aqueous humor production, decrease metabolism, decrease renin secretion (why its useful in CG), decreases lipolysis. |  | 
        |  | 
        
        | Term 
 
        | Muscarinic Agonist Methylcholine, pilocarpine, carbachol, bethanechol |  | Definition 
 
        | MOA: Enhance the activity of the muscarinic receptor   Use: Dx of asthma, decrease intraocular pressure, urinary retention, neurogenic bladder, M1 effects help in cognition   SE: SLUG BAM |  | 
        |  | 
        
        | Term 
 
        | Muscarinic Antagonists Atropine, Scopalomine, Dimenhydramine, Ditropan, Vesicare, ENeblex, Atrovent, Spiriva |  | Definition 
 
        | MOA: Decrease activity of Ach at the muscarinic receptor   Uses: Anethesia, Bradycardia, Motion Sickness, Overactive Bladder, Asthma, COPD   SE: ABCDs=anorexia, blurred vision, constipation, dry mouth, sedation |  | 
        |  | 
        
        | Term 
 
        | Nicotinic Agonists: Succcinylcholine, Nicoderm, Chantix |  | Definition 
 
        | MOA: Activate cholinergic channels causing depolarization of the cell membrance and blockading them open, agent must stay and agonize the site for channel to say open and continuously activate nicotinic receptors, paralysis occurs do to continously open channels   Uses: Paralysis, Nictoine supplement |  | 
        |  | 
        
        | Term 
 
        | Nictoinic Antagonist: Vancornium, rocuronium, Vecuronium |  | Definition 
 
        | MOA: prevents Ach from attaching to N receptors causing muscle cell deploarization causes a non-depolaring neuromuscular blackage   Uses: Paralysis in surgery/ anethesia |  | 
        |  | 
        
        | Term 
 
        | Acetylcolinesterase Inhibitors Pyridostigmine, neostigmine, tacrine, aricept |  | Definition 
 
        | MOA: blocks the breakdown of Ach, causing elevated levels of Ach in the synapses   Uses: Myasthenia gravis incrase transmission, increase GI motility, Alzheimers to increase central cholinergic activity   SE: NVD, gas   CI: people with severe heart dz, untreated epilepsy, and active peptic ulcer dz. |  | 
        |  | 
        
        | Term 
 
        | Effects of Sympathomimetic drugs (Agonist)   A1 (Epi, norepi)-non selective, dopamine, phenylephrine, clonidine, osymetazoline, tetrahydrozoline, xylometazoline |  | Definition 
 
        | Vasoconstriction, increase BP, Dilate pupils for far vision, increase humor outflow, decrease mucosal secretion (decongetion), urinary continence, ejaculation |  | 
        |  | 
        
        | Term 
 
        | Effects of Sympathomimetic drugs (Agonist)   A2 (epi, norepi)-nonselective, Clonidine, apraclonidine, phenylephrine |  | Definition 
 
        | decrease BP, neg. feedback, increase humor outflow, decrease peristalisis, decrease digestive |  | 
        |  | 
        
        | Term 
 
        | Effects of Sympathomimetic drugs (Agonist)   B1 Epi, dobutamine, albuterol , Dopamine |  | Definition 
 
        | Increse CO and BP,increase production of aqueous humor |  | 
        |  | 
        
        | Term 
 
        | Effects of Sympathomimetic drugs (Agonist)   B2 Epinephrine, Ritodrine, Albuterol, Terbutaline, Dobutamine |  | Definition 
 
        | peripheral vasodilation, decrease BP, dilate broncholes, decrease peristalisis, relaxtion so decreases urinary output, relaxtion so inhibits labor |  | 
        |  | 
        
        | Term 
 
        | Effects of Sympathomimetic drugs (Agonist)   D1 Dopamine, Fenoldopam |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Effects of Sympathomimetic drugs (Agonist)   D2 Dopamine |  | Definition 
 
        | Modulated transmitter release nerve endings. |  | 
        |  |